SCHEMBL3705247

SCHEMBL3705247

COC(=O)C(NC(=O)OC(C)(C)C)c1ccc(O)c(C)c1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
AAK1 Q2M2I8 1/20 0.38
S1PR3 Q99500 2/20 0.38
MT-CO2 P00403 1/20 0.38
KLK5 Q9Y337 1/20 0.38
MAPT P10636 1/20 0.37
SRC P12931 2/20 0.36
FOLH1 Q04609 4/20 0.36
PDE2A O00408 1/20 0.35
PPARG P37231 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11353719 0.88 CTSS (0.44) CTSSCTSKS1PR3MAPTFOLH1
SCHEMBL3775563 0.86 FOLH1 (0.50) FOLH1
SCHEMBL16044610 0.82 CTSK (0.41) CTSSCTSKAAK1
SCHEMBL16044609 0.82 CTSK (0.41) CTSSCTSKAAK1
SCHEMBL1554122 0.82 CTSS (0.48) CTSSCTSKS1PR3KLK5MAPT
SCHEMBL14254331 0.82 CTSS (0.48) CTSSCTSKS1PR3KLK5MAPT
SCHEMBL2582580 0.82 CTSS (0.48) CTSSCTSKS1PR3KLK5MAPT
SCHEMBL1554126 0.82 CTSS (0.48) CTSSCTSKS1PR3KLK5MAPT
SCHEMBL3619414 0.80 CTSS (0.47) CTSSCTSKS1PR3KLK5MAPT
SCHEMBL20752378 0.78 AAK1 (0.40) CTSSCTSKAAK1S1PR3KLK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217592-A1 BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2010-08-18 EP disclosed
WO-2009058300-A1 BIPHENYL DERIVATIVES AS MODULATORS OF THE HISTAMINE-H3 RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2009-05-07 WO disclosed